Pacitti David
Known title: DirectorCIK: 0001722733
Associated companies
Transaction History
| OBIO | ▼ Sell | Tax Withholding | 3,761 | $17K | 8/12/2026 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 3,784 | $0 | 6/24/2026 | View on chart |
| OBIO | ▲ Buy | Grant | 17,327 | $0 | 6/23/2026 | View on chart |
| OBIO | ▲ Buy | Grant | 15,000 | $0 | 8/7/2025 | View on chart |
| OBIO | ▲ Buy | Grant | 12,422 | $0 | 6/24/2025 | View on chart |
| OBIO | ▲ Buy | Grant | 5,376 | $0 | 6/20/2024 | View on chart |
| OBIO | ▲ Buy | Grant | 10,000 | $0 | 3/26/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
OBIO Shares Rise 5.2% Amid Positive Momentum
Orchestra BioMed Holdings (OBIO) shares recently increased by 5.2%, a move that some observers see as a sign of strengthening momentum. The stock currently trades within its 52-week range of $2.20 to $6.48. Analysts maintain an average price target of $12.14, suggesting a significant gap between the current market price and professional estimates.
OBIO Shares Rise 5.2% Amid Positive Momentum. Orchestra BioMed Holdings (OBIO) shares recently increased by 5.2%, a move that some observers see as a sign of strengthening momentum. The stock currently trades within its 52-week range of $2.20 to $6.48. Analysts maintain an average price target of $12.14, suggesting a significant gap between the current market price and professional estimates.